Evidence-based laboratory medicine - A guide for critical evaluation of in vitro laboratory testing

Annals of Clinical Biochemistry

Volumn 44, Issue 2, 2007, Pages 111-130

  Christenson, Robert H ^a  

^a UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAREGIVER; DIAGNOSTIC PROCEDURE; EVIDENCE BASED MEDICINE; HUMAN; IN VITRO STUDY; LABORATORY DIAGNOSIS; LABORATORY TEST; PHYSICIAN; PREDICTION; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY;

CLINICAL CHEMISTRY TESTS; EVIDENCE-BASED MEDICINE; GUIDELINES; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES;

EID: 34047098367     PISSN: 00045632     EISSN: 00045632     Source Type: Journal    
DOI: 10.1258/000456307780118127     Document Type: Review

References (41)

1. McGlynn EA, Asch SM, Adams J, et al. The quality of health care delivered to adults in the United States. N Engl J Med 2003; 348: 2635-45
2. Price CP. Evidence-based laboratory medicine: supporting decision-making. Clin Chem 2000; 46: 1041-50
3. Guder WG. Preanalytical factors and their influence on analytical quality specifications. Scand J Clin Lab Invest 1999; 59: 545-9
4. Sackett DL, Haynes RB, Guyatt GH, Tugwell P. Clinical Epidemiology; a Basic Science for Clinical Medicine. 2nd edn. Toronto: Little, Brown, 1991; 1-441
5. Klovning A, Sandberg S. Searching the literature and relevant databases. In: CP Price, RH Christenson, eds. Evidence Based Laboratory Medicine: From Principles to Outcomes. Washington DC: AACC Press, 2003; 93-114
6. Reid MC, Lachs MS, Feinstein AR. Use of methodological standards in diagnostic test research. Getting better but still not good. JAMA 1995; 274: 645-51
7. Lijmer JG, Mol BW, Heisterkamp S, et al. Empirical evidence of design-related bias in studies of diagnostic tests. JAMA 1999; 282: 1061-6
8. Moher D, Jones A, Lepage L. Use of the CONSORT statement and quality of reports of randomized trials. A comparative beforeand-after evaluation. JAMA 2001; 285: 1992-5
9. Bossuyt PM, Reitsma JB, Bruns DE, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Ann Clin Biochem 2003; 40: 357-63
10. Lumbreras-Lacarra B, Ramos-Rincon JM, Hernandez-Aguado I. Methodology in diagnostic laboratory test research in clinical chemistry and clinical chemistry and laboratory medicine. Clin Chem 2004; 50: 530-6
11. Horvath AR, Pewsner D, Egger M. Systematic reviews in laboratory medicine: potentials, principles and pitfalls. In: Price CP, Christenson RH, eds. Evidence Based Laboratory Medicine: From Principles to Outcomes. Washington DC: AACC Press, 2003; 93-114
12. Hunt DL, McKibbon KA. Locating and appraising systematic reviews. Ann Intern Med 1997; 126: 532-8
13. Whiting P, Rutjes AWS, Rietsma JB, et al. Sources of variation and bias in studies of diagnostic accuracy. Ann Intern Med 2004; 140: 189-202
14. Moja LP, Telaro E, D'Amico R, Moschetti I, Coe L, Liberati A. Assessment of methodological quality of primary studies by systematic reviews: results of the metaquality cross sectional study. BMJ 2005; 330: 1053
15. Guyatt G, Rennie D, eds. Users Guides: Essentials of Evidence-Based Clinical Practice. Chicago, IL: American Medical Association, 2002
16. Mueller C, Scholer A, Laule-Kilian K, et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med 2004; 350: 647-54
17. Maisel A, Hollander JE, Guss D, et al. Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath. J Am Coll Cardiol 2004; 44: 1328-33
18. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342: 836-43
19. Boyd JC, Deeks JJ. Analysis and presentation of data. In: Price CP, Christenson RH, eds. Evidence Based Laboratory Medicine: From Principles to Outcomes. Washington DC: AACC Press, 2003; 115-36
20. Systems to Rate the Strength of Scientific Evidence. Summary, Evidence Report/Technology Assessment: Number 47. AHRQ Publication No. 02-E015, March 2002 Rockville, MD: Agency for Healthcare Research and Quality, 2002; http://www.ahrq.gov/clinic/epcsums/strengthsum.htm
21. Deeks JJ. Systematic reviews of evaluations of diagnostic and screening tests. BMJ 2001; 323: 157-62
22. Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PM. The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol 2003; 56: 1129-35
23. Wieczorek SJ, Wu AH, Christenson R, et al. A rapid B-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure: a multicenter evaluation. Am Heart J 2002; 144: 834-9
24. Hanley JA, McNeil BJ. The meaning and use of area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143: 29-36
25. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating curves: a nonparametric approach. Biometrics 1988; 44: 837-45
26. Wu AH, Valdes Jr R, Apple FS, et al. Cardiac troponin-T immunoassay for diagnosis of acute myocardial infarction. Clin Chem 1994; 40: 900-7
27. Moses LM, Shapiro D, Littenberg B. Combining independent studies of a diagnostic test into a summary ROC curve: data analytic considerations and some additional considerations. Stat Med 1993; 12: 1293-316
28. McCullough PA, Nowak RM, McCord J, et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from breathing not properly (BNP) multinational study. Circulation 2002; 106: 416-22
29. Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002; 347: 161-7
30. Christenson RH, Maynard S, Dunston RC, et al. Application of N-terminal proBNP and b-type natriuretic peptide in a large community cohort: similarities and differences for diagnosing heart failure and predicting mortality. Circulation 2005; 215(Suppl): 531
31. Moons KG, Donders AR, Steyerberg EW, Harrell FE. Penalized maximum likelihood estimation to directly adjust diagnostic and prognostic prediction models for overoptimism: a clinical example. J Clin Epidemiol 2004; 57: 1262-70
32. Bradbury CJ, Cummins E, Downie S, Foster L, Stout A. National Health Service Quality Improvement Scotland. Health Technology Report 6. The use of B-type natriuretic peptides (BNP and NT-proBNP) in the investigation of patients with suspected heart failure. 2005; 1-142
33. Fagan TJ. Letter: Nomogram for Bayes theorem. N Engl J Med 1975; 293: 257
34. Guyatt GH, Patterson C, Ali M, et al. Diagnosis of iron-deficiency anemia in the elderly. Am J Med 1990; 88: 205-9
35. Brown MD, Rowe BH, Reeves MJ, Bermingham JM, Goldhaber SZ. The accuracy of the enzyme-linked immunosorbent assay D-dimer test in the diagnosis of pulmonary embolism: a meta-analysis. Ann Emerg Med 2002; 40: 133-44
36. James SK, Lindahl B, Siegbahn A, et al. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a global utilization of strategies to open occluded arteries (GUSTO)-IV substudy. Circulation 2003; 108: 275-81
37. Guyatt GH, Oxman AD, Ali M, Willan A, McIlroy W, Patterson C. Laboratory diagnosis of iron-deficiency anemia: an overview. J Gen Intern Med 1992; 7: 145-53
38. Woolf SH, Grol R, Hutchinson A, Eccles M, Grimshaw J. Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines. BMJ 1999; 318: 527-30
39. Shekelle PG, Woolf SH, Eccles M, Grimshaw J. Clinical guidelines: developing guidelines. BMJ 1999; 318: 593-6
40. Lugon M, Secker-Walker J, eds. Clinical Governance: Making it Happen. London: Royal Society of Medicine Press, 1999; 1-222
41. Krumholz HM, Herrin J. Quality improvement studies: the need is there but so are the challenges. Am J Med 2000; 109: 501-3